Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study

Juan E. Blümel,Eugenio Arteaga,Sócrates Aedo,Jose Arriola-Montenegro,Marcela López,Mabel Martino,Carlos Miranda,Octavio Miranda,Desiree Mostajo,Mónica Ñañez,Eliana Ojeda,Susana Pilnik,José Luis Rojas,Carlos Salinas,Lida Sosa,Poli Mara Spritzer,Konstantinos Tserotas,María S. Vallejo,Alejandra Belardo,Tayane Muniz Fighera,Peter Chedraui

Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study

2020

AbstractMetformin may decrease cell senescence, including bone; hence we aimed at evaluating the association between metformin use and osteoporosis. This was a cross-sectional study carried out in ...

Keywords:

Internal medicine
Endocrinology
Metformin
Medicine
Senescence
Diabetes mellitus
Osteoporosis
Type 2 Diabetes Mellitus
Lower risk
Obesity
adult women

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations